Multiple Myeloma Treatment

multiple myeloma
Multiple myeloma
seen in bone marrow
Image by KGH

Approximately 20,000 new cases of multiple myeloma are diagnosed each year in the United States 1. It is a cancer that forms in the plasma cells, a type of white blood cell, which produces antibodies to help the body fight off germs and infections.

When the plasma cells reproduce rapidly and become cancerous, these cells tend to collect in the bone marrow, causing the bone marrow to not be able to produce enough red blood cells, platelets or white blood cells. This leads to problems such as anemia, bruising and bleeding, making it hard for the body to fight off the infections. Additionally, it causes bones to become weak and eventually break.

Treatment options for multiple myeloma can include one or more of the following:

Chemotherapy and Other Specialized Treatments
Chemotherapy is commonly used to treat multiple myeloma because it enters the bloodstream and travels throughout the body to destroy cancerous cells. It is commonly given in combination with other specialized multiple myeloma drugs called corticosteroids, thalidomide, lenalidomide and/or bortezomib.
Given intravenously, these therapies are given because they strengthen bone and help prevent fractures associated with multiple myeloma. Commonly used bisphosphonates include pamidronate and zoledronic acid.
Radiation Therapy
This type of treatment is usually reserved for multiple myeloma that has not responded to other treatments. It may be used to treat some areas of bone that still have cancer or relieve pain and other symptoms caused by the spread of the multiple myeloma.
Biological Therapy
The use of specialized treatments that produce proteins that are normally found in the body to fight off infections. Interferon is sometimes given to patients to try to slow the growth of myeloma cells. Another biological therapy called erthyropoietin is given to help fight anemia, or increase the levels of red blood cells in the blood.
Stem Cell Transplant
This form of treatment occurs when high doses of chemotherapy or radiation are given to destroy bone marrow cells (where white blood cells develop) and then are replaced with healthy stem cells, which form new white blood cells, previously removed from the patient or a donor.


  1. National Cancer Institute, Multiple Myeloma/Other Plasma Cell Neoplasms Home Page. Accessed on July 31, 2010.

Related Articles

Hodgkin's lymphoma treatment

Non-Hodgkin's lymphoma treatment

Bone marrow cancer survival rate


The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational purposes and does not constitute the practice of medicine. We encourage all visitors to see a licensed physician or nutritionist if they have any concerns regarding health issues related to diet, personal image and any other topics discussed on this site. Neither the owners or employees of nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.